Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07574593
NORM-HF Pivotal StudyBaim Institute for Clinical ResearchNot Yet RecruitingNot Applicable
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07574463
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's HospitalNot Yet RecruitingNot Applicable
NCT07574463Not Yet Recruiting
Not Applicable
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's Hospit...
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07576322
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University Hospitals, SwitzerlandNot Yet RecruitingNot Applicable
NCT07576322Not Yet Recruiting
Not Applicable
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University...
NCT07574827
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private UniversityRecruiting
NCT07574827Recruiting
—
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private Univers...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07574970
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS - A PILOT RCT IN INDIAN POPULATIONAsian Institute of Gastroenterology, IndiaRecruiting
NCT07574970Recruiting
—
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFT...Asian Institute of Gastro...
NCT07576465
Effects of SBMT Combined With NMES on UL Functions in Post Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07576465Recruiting
Not Applicable
Effects of SBMT Combined With NMES on UL Functions in Post Stroke PatientsRiphah International Univ...
NCT07575360
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis PatientsUniversity of BolognaCompleted
NCT07575360Completed
—
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Chole...University of Bologna
NCT07574619
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based ApproachMU-JHU CARENot Yet RecruitingNot Applicable
NCT07574619Not Yet Recruiting
Not Applicable
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Cou...MU-JHU CARE
NCT07574710
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability in Immediate Implant Placement: A Clinical Study With 1-Year Post-Restorative ResultsTomas LinkeviciusCompletedNot Applicable
NCT07574710Completed
Not Applicable
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability...Tomas Linkevicius
NCT07575737
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative and Mortality and MorbidityKarolinska InstitutetCompleted
NCT07575737Completed
—
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative...Karolinska Institutet
NCT07576387
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare HamiltonNot Yet RecruitingNot Applicable
NCT07576387Not Yet Recruiting
Not Applicable
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare H...
NCT07575646
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel EtchingCairo UniversityNot Yet RecruitingNot Applicable
NCT07575646Not Yet Recruiting
Not Applicable
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective...Cairo University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07574489
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of NebraskaNot Yet RecruitingPhase 2
NCT07574489Not Yet Recruiting
Phase 2
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of Nebraska
NCT07574541
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07574541Not Yet Recruiting
Phase 2
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno)...National Cancer Institute...
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting4 (20%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 11 (5%)
Phase 31 (5%)